Martin Štěrba

4.4k total citations · 1 hit paper
72 papers, 2.6k citations indexed

About

Martin Štěrba is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Martin Štěrba has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cardiology and Cardiovascular Medicine, 18 papers in Pathology and Forensic Medicine and 13 papers in Molecular Biology. Recurrent topics in Martin Štěrba's work include Chemotherapy-induced cardiotoxicity and mitigation (42 papers), Cardiac Ischemia and Reperfusion (12 papers) and Electron Spin Resonance Studies (9 papers). Martin Štěrba is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (42 papers), Cardiac Ischemia and Reperfusion (12 papers) and Electron Spin Resonance Studies (9 papers). Martin Štěrba collaborates with scholars based in Czechia, Canada and United Kingdom. Martin Štěrba's co-authors include Tomáš Šimůnek, Vladimír Geršl, Olga Popelová, Michaela Adamcová, Radomír Hrdina, Eduard Jirkovský, Y Mazurová, Petra Kovařı́ková, Anna Vávrová and Přemysl Poňka and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Martin Štěrba

67 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

2009 633 citations Tomáš Šimůnek, Martin Štěrba et al. profile →

Peers

Martin Štěrba

CCM

ONCOL

PFM

PRM

Eugene H. Herman United States

Vladimír Geršl Czechia

Tomáš Šimůnek Czechia

Eugene A. Konorev United States

Olga Popelová Czechia

Nicola Maurea Italy

Vilma A. Sardão Portugal

Beshay N. Zordoky United States

Radomír Hrdina Czechia

Vijay Kumar Kutala India

Eugene H. Herman United States

Martin Štěrba

2.2k ×1.5

CCM

874 ×1.3

ONCOL

724 ×1.1

374 ×1.0

PFM

393 ×1.3

PRM

Citations per year, relative to Martin Štěrba Martin Štěrba (= 1×) peers Eugene H. Herman

Countries citing papers authored by Martin Štěrba

Since Specialization

Citations

This map shows the geographic impact of Martin Štěrba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Štěrba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Štěrba more than expected).

Fields of papers citing papers by Martin Štěrba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Štěrba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Štěrba. The network helps show where Martin Štěrba may publish in the future.

Co-authorship network of co-authors of Martin Štěrba

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Štěrba. A scholar is included among the top collaborators of Martin Štěrba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Štěrba. Martin Štěrba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abad, Cilia, Ivana Musilová, Ramón Portillo, et al.. (2025). Impact of intraamniotic inflammation on tryptophan metabolism in the placenta-fetal brain axis in rats. Reproduction. 169(5).

Štěrba, Martin, et al.. (2025). Methodological Aspects of μLC-MS/MS for Wide-Scale Proteomic Analysis of Anthracycline-Induced Cardiomyopathy. ACS Omega. 10(12). 11980–11993.

Husková, Zuzana, Janusz Sadowski, Lenka Hošková, et al.. (2024). Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats. Hypertension Research. 47(11). 3126–3146. 1 indexed citations

Suchánek, Petr & Martin Štěrba. (2018). An analysis of value creation in Czech food companies. SHILAP Revista de lepidopterología.

Štěrba, Martin, et al.. (2017). Proceedings of the International Scientific Conference of Business Economics Management and Marketing 2019. 3 indexed citations

Jirkovský, Eduard, Jan Bureš, Jaroslav Chládek, et al.. (2017). Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart. Journal of Pharmacology and Experimental Therapeutics. 364(3). 433–446. 19 indexed citations

Štěrba, Martin, et al.. (2015). From Knowledge Management to Ecosystems of Innovation: A Scoping Review. Management Science. 10(1). 79–85. 1 indexed citations

Shehabi, Yahya, Martin Štěrba, Peter Garrett, et al.. (2014). Procalcitonin Algorithm in Critically Ill Adults with Undifferentiated Infection or Suspected Sepsis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 190(10). 1102–1110. 130 indexed citations

Vávrová, Anna, Hana Jansová, Miloslav Macháček, et al.. (2013). Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells. PLoS ONE. 8(10). e76676–e76676. 59 indexed citations

10.

Štěrba, Martin, Olga Popelová, Anna Vávrová, et al.. (2012). Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection. Antioxidants and Redox Signaling. 18(8). 899–929. 276 indexed citations

11.

Štěrba, Martin, et al.. (2008). Prospective observational study of levosimendan and weaning of difficult-to-wean ventilator-dependent intensive care patients. Critical Care and Resuscitation. 10(3). 182–186. 24 indexed citations

12.

Šimůnek, Tomáš, Martin Štěrba, Olga Popelová, et al.. (2008). Pyridoxal Isonicotinoyl Hydrazone (PIH) and its Analogs as Protectants Against Anthracycline-Induced Cardiotoxicity. Hemoglobin. 32(1-2). 207–215. 7 indexed citations

13.

Adamcová, Michaela, Tomáš Šimůnek, Helena Mertlíková‐Kaiserová, et al.. (2007). In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity. Toxicology. 237(1-3). 218–228. 50 indexed citations

14.

Štěrba, Martin, Olga Popelová, Tomáš Šimůnek, et al.. (2007). Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH). Toxicology. 235(3). 150–166. 29 indexed citations

15.

Kovařı́ková, Petra, Jiřı́ Klimeš, Martin Štěrba, et al.. (2006). HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study. Journal of Chromatography B. 838(2). 107–112. 14 indexed citations

16.

Grossbard, E, Tim Mant, Stipo Jurčević, & Martin Štěrba. (2005). A multiple dose study of an orally bioavailable inhibitor of SyK-kinase (r406) in human volunteers: Safety, pharmacokinetics (PK) and pharmacodynamics (PD). Research Portal (King's College London). 52(9). 1 indexed citations

17.

Šimůnek, Tomáš, Christa Boer, R. Arthur Bouwman, et al.. (2005). SIH—a novel lipophilic iron chelator—protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. Journal of Molecular and Cellular Cardiology. 39(2). 345–354. 83 indexed citations

18.

Šimůnek, Tomáš, Y Mazurová, Michaela Adamcová, et al.. (2003). Rabbit Model for in Vivo Study of Anthracycline-Induced Heart Failure and for the Evaluation of Protective Agents. European Journal of Heart Failure. 6(4). 377–387. 49 indexed citations

19.

Adamcová, Michaela, Martin Štěrba, Tomáš Šimůnek, et al.. (2003). Cardiac Troponins Following Repeated Administration of an Iron Chelator – Salicylaldehyd Isonicotinoyl Hydrazone (SIH) – in Rabbits. Acta Medica (Hradec Kralove Czech Republic). 46(4). 171–174. 4 indexed citations

20.

Šimůnek, Tomáš, Martin Štěrba, Radomír Hrdina, et al.. (2003). A Study of Potential Toxic Effects After Repeated 10-Week Administration of a New Iron Chelator – Salicylaldehyde Isonicotinoyl Hydrazone (SIH) to Rabbits. Acta Medica (Hradec Kralove Czech Republic). 46(4). 163–170. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact